Society guideline links: Allergen immunotherapy for the treatment of respiratory allergy

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Allergic Rhinitis and its Impact on Asthma (ARIA)-European Academy of Allergy and Clinical Immunology (EAACI): Care pathways for allergen immunotherapy in respiratory allergy (2021)

●ARIA: Care pathways for allergen immunotherapy (2019)

●International Consensus (ICON): Allergy immunotherapy II – Mechanisms, standardization, and pharmacoeconomics (2016)

●ICON: Position paper on allergy immunotherapy (2015)

●World Allergy Organization (WAO): Statement on allergen immunotherapy on the way to product-based evaluation (2015)

●WAO: Position paper on sublingual immunotherapy, 2013 update (published 2014)

●WAO Taskforce: Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy – A statement (2007)

Canada

●Canadian Society of Allergy and Clinical Immunology (CSACI): Position statement on prescribing sublingual immunotherapy tables for aeroallergens (2018)

●CSACI: Consensus guidelines on practical issues of immunotherapy (2006)

United States

●American Academy of Allergy, Asthma, and Immunology (AAAAI): A work group report on allergen immunotherapy extract shortages and their effects on clinical care (2022)

●Joint Task Force on Practice Parameters (JTFPP): A focused allergen immunotherapy practice parameter on sublingual immunotherapy, update (2017)

●AAAAI/European Academy of Allergy and Clinical Immunology (EAACI): PRACTALL consensus report on allergen immunotherapy, update (2013)

●JTFPP: A practice parameter on allergen immunotherapy, third update (2011)

•JTFPP: A practice parameter on allergen immunotherapy, second update (2007)

•JTFPP: A practice parameter on allergen immunotherapy (2003)

Europe

●Allergic Rhinitis and its Impact on Asthma (ARIA)-European Academy of Allergy and Clinical Immunology (EAACI): Care pathways for allergen immunotherapy in respiratory allergy (2021)

●EAACI: Position paper on placebo effects in allergen immunotherapy (2020)

●EAACI: Guidelines on allergen immunotherapy – House dust-mite driven allergic asthma (2019)

●EAACI: Guidelines on allergen immunotherapy – Allergic rhinoconjunctivitis (2018)

●EAACI: Position paper on allergen immunotherapy in people, dogs, cats, and horses – Differences, similarities, and research needs (2018)

●EAACI: Allergen immunotherapy guidelines (2017)

●EAACI: Position paper on biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma (2017)

●EAACI: Position paper on defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis (2017)

●EAACI: Clinical contraindications to allergen immunotherapy – A position paper (2015)

●EAACI: Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis – A position paper (2014)

●American Academy of Allergy, Asthma, and Immunology (AAAAI)/EAACI: PRACTALL consensus report – Update on allergen immunotherapy (2013)

●EAACI: Position statement on perspectives on allergen-specific immunotherapy in childhood (2012)

●EAACI: Report on "dose-response relationship in allergen-specific immunotherapy" (2011)

●Global Allergy and Asthma European Network (GA2LEN): The CONSORT statement checklist in allergen-specific immunotherapy (2009)

Australia–New Zealand

●Australasian Society of Clinical Immunology and Allergy (ASCIA): A guide for clinical immunology/allergy specialists on aeroallergen immunotherapy (2019)

●Choosing Wisely Australia: Allergen immunotherapy should not yet be used for routine treatment of food allergy – research in this area is ongoing (2017)

Japan

●[In Japanese] Japanese Society of Allergology (JSA): A guide to allergen immunotherapy (2022)